Researchers from the agency partnered with eight U.S. health departments for the study. They used population-based surveillance data for patients infected by carbapenem-resistant Enterobacterales from January 2012 to December 2015. Most of the infections were observed in women with urinary tract infections.
Their findings were published July 27 in the American Journal of Infection Control.
“CRE cause difficult-to-treat infections and have the potential to spread rapidly, including outside of the healthcare setting, where most cases currently occur … and some Enterobacterales are common causes of infection that occur in the community already,” Sandra Bulens, CDC epidemiologist and lead study author, told CIDRAP News. “So there’s a real potential for these organisms to spread into the community.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.